Proteasome Inhibition and Combination Therapy for Non-Hodgkin's Lymphoma: From Bench to Bedside.

MLA

Mato, Anthony R., et al. “Proteasome Inhibition and Combination Therapy for Non-Hodgkin’s Lymphoma: From Bench to Bedside.” Oncologist, vol. 17, no. 5, May 2012, pp. 694–707. EBSCOhost, https://doi.org/10.1634/theoncologist.2011-0341.

APA

Mato, A. R., Feldman, T., & Goy, A. (2012). Proteasome Inhibition and Combination Therapy for Non-Hodgkin’s Lymphoma: From Bench to Bedside. Oncologist, 17(5), 694–707. https://doi.org/10.1634/theoncologist.2011-0341

Chicago

Mato, Anthony R., Tatyana Feldman, and Andr Goy. 2012. “Proteasome Inhibition and Combination Therapy for Non-Hodgkin’s Lymphoma: From Bench to Bedside.” Oncologist 17 (5): 694–707. doi:10.1634/theoncologist.2011-0341.